Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bond

Showing results (301-310 of 310) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 310 results.
BJS Open|November 5, 2025
One-stage versus two-stage surgery for initially unresectable colorectal cancer liver metastases: post hoc analysis of the CAIRO5 trialMarinde J G Bond, Karen Bolhuis, Martinus J van Amerongen, et al.
Ebiomedicine|December 17, 2025
Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastasesNerma Crnovrsanin, J Michiel Zeeuw, Mahsoem Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2023
The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trialKaren Bolhuis, Marinde J G Bond, Martin J Van Amerongen, et al.
Annals of Surgical Oncology|April 28, 2023
Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer GroupMarinde J G Bond, Babette I Kuiper, Karen Bolhuis, et al.
JAMA Oncology|November 21, 2024
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical TrialMarinde J G Bond, Karen Bolhuis, Olaf J L Loosveld, et al.
The Lancet. Oncology|June 17, 2023
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J G Bond, Karen Bolhuis, Olaf J L Loosveld, et al.
Viruses|November 27, 2021
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra LeoneansRodrigo Borrega, Diana K S Nelson, Anatoliy P Koval, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2024
Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validationJ Michiel Zeeuw, Nina J Wesdorp, Mahsoem Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trialJ Michiel Zeeuw, Ruby Kemna, Mahsoem Ali, et al.
Viruses|August 28, 2021
The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and ResponseYolanda Botti-Lodovico, Parvathy Nair, Dolo Nosamiefan, et al.
Pageof 31

Showing results (301-310 of 310) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 310 results.
BJS Open|November 5, 2025
One-stage versus two-stage surgery for initially unresectable colorectal cancer liver metastases: post hoc analysis of the CAIRO5 trialMarinde J G Bond, Karen Bolhuis, Martinus J van Amerongen, et al.
Ebiomedicine|December 17, 2025
Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastasesNerma Crnovrsanin, J Michiel Zeeuw, Mahsoem Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2023
The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trialKaren Bolhuis, Marinde J G Bond, Martin J Van Amerongen, et al.
Annals of Surgical Oncology|April 28, 2023
Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer GroupMarinde J G Bond, Babette I Kuiper, Karen Bolhuis, et al.
JAMA Oncology|November 21, 2024
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical TrialMarinde J G Bond, Karen Bolhuis, Olaf J L Loosveld, et al.
The Lancet. Oncology|June 17, 2023
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J G Bond, Karen Bolhuis, Olaf J L Loosveld, et al.
Viruses|November 27, 2021
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra LeoneansRodrigo Borrega, Diana K S Nelson, Anatoliy P Koval, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2024
Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validationJ Michiel Zeeuw, Nina J Wesdorp, Mahsoem Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trialJ Michiel Zeeuw, Ruby Kemna, Mahsoem Ali, et al.
Viruses|August 28, 2021
The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and ResponseYolanda Botti-Lodovico, Parvathy Nair, Dolo Nosamiefan, et al.
Pageof 31